Ishii, Masanobu
Seki, Tomotsugu
Sakamoto, Kenji
Kaikita, Koichi
Miyamoto, Yoshihiro
Tsujita, Kenichi
Masuda, Izuru
Kawakami, Koji
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP19K17531)
Japan Society of Ningen Dock (2019-7)
Article History
Received: 4 August 2020
Accepted: 22 September 2020
First Online: 19 October 2020
Competing interests
: All authors declare no potential conflict of interest in connection with this paper. Moreover, a potential conflict of interest unrelated to this paper: Dr. Seki reports personal fees from Pfizer.inc., outside the submitted work. Dr. Kaikita reports grants and other from Bayer Yakuhin, Ltd., grants and other from Daiichi Sankyo Co., Ltd., grants from Novartis Pharma K.K., grants from SBI pharma K.K., from null, outside the submitted work. Dr. Sakamoto reports grants from Daiichi-Sankyo Co., Ltd., outside the submitted work. Dr. Tsujita reports personal fees from Novartis Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Nippon Boehringer Ingelheim Co., Ltd., personal fees from Daiichi Sankyo Co., Ltd., personal fees from MSD K.K., personal fees from Mitsubishi Tanabe Pharm Corp., grants from Teijin Pharm Ltd., personal fees from Bristol-Myers Squibb Company, personal fees from Takeda Pharmaceutical Co., Ltd., personal fees from Otsuka Pharmaceuticals Co., Ltd., personal fees from Astellas Parma Inc., grants from AstraZeneca K.K., personal fees from Sanofi K.K., personal fees from Cardinal Health Japan Inc., personal fees from Goodman Co., LTD., personal fees from Chugai Pharmaceutical Co, Ltd., personal fees from Boston Scientific Japan K.K., personal fees from Kowa Pharmaceutical Co. Ltd., personal fees from Pfizer Japan Inc., personal fees from Shionogi & Co., outside the submitted work. Dr. Kawakami reports personal fees from Shin Nippon Biomedical Laboratories, Ltd., JMDC Inc., Agree Co., Ltd., stock ownership from Real World Data, Co., Ltd., grants from Kyowa Kirin, Co., Ltd., grants from Real World Data, Co., Ltd., grants from Mitsubishi Corporation, grants from Novartis Pharma K.K., grants from Suntory Beverage & Food Limited, grants from Sumitomo Dainippon Pharma Co., Ltd., grants from Medical Platform Co. Ltd., grants from STELLA PHARMA CORPORATION, grants from Pfizer Inc., grants from Tanabe Mitsubishi pharm, outside the submitted work. Other authors declare no potential conflict of interest.